Status:
COMPLETED
(LARS) Score Validation of Turkish Language
Lead Sponsor:
Ankara University
Collaborating Sponsors:
Aarhus University Hospital
Dokuz Eylul University
Conditions:
LARS - Low Anterior Resection Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Long-term bowel dysfunction after resection for rectal cancer, known as low anterior resection syndrome (LARS), is observed in many patients. The LARS score was developed to measure this syndrome and ...
Detailed Description
A total of 326 patients were reviewed and contacted for the study, and 222 (68%) were eligible for the analyses. The association between the LARS score and quality of life and the test-retest reliabil...
Eligibility Criteria
Inclusion
- The inclusion criteria were
- rectal adenocarcinoma within 15 cm from the anal verge
- LAR with either PME or TME.
- Bowel continuity restored for at least 18 months when invited for the study.
Exclusion
- Exclusion criteria included
- failed R0 surgery,
- recurrence or dissemination,
- having intestinal stoma,
- previous cancer (except minor skin cancers)
- dementia and inability to speak Turkish (i.e., the need for a translator during treatment).
Key Trial Info
Start Date :
February 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2020
Estimated Enrollment :
222 Patients enrolled
Trial Details
Trial ID
NCT05289531
Start Date
February 1 2016
End Date
February 28 2020
Last Update
March 21 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.